|
Is anyone bothered by the fact that Lipitor is being recommended for
DAILY use in areas other than cholesterol, because of the "
benefits"? Lipitor is even being studied for its use in regulating
autoimmune disease. Pathways unrelated to the cholesterol pathway
are affected, most notably the inhibition of isoprenylation
reactions that are essential to the activation of Rho family GTPases.
Interestingly enough, a natural ingredient, policosanol, has not
only been tested in clinical trials against Lipitor, it affects the
same isoprenylation pathway as well. Some researchers out there are
actually pointing out the obvious - why not consider using something
natural like policosanol? In their own words, "A comparable regimen,
in which policosanol is used in place of statins, may represent a
practical strategy whereby nearly everyone willing to commit to
health-protective eating can either prevent coronary disease, or
prevent pre-existing coronary disease from progressing to a
life-threatening event" (McCarty MF. Policosanol safely
down-regulates HMG-CoA reductase - potential as a component of the
Esselstyn regimen. Med Hypotheses. 2002 Sep;59(3):268-79.) The same
researchers point out that "unlike statins, policosanol does not
directly inhibit HMG-CoA reductase (the cholesterol synthesizing
enzyme), and even in high concentrations it fails to down-regulate
this enzyme by more than 50% - thus likely accounting for the safety
of this nutraceutical..." (McCarty MF ibid). Below is an abstract that describes a clinical trial conducted on
Lipitor and policosanol, demonstrating that policosanol lowered
cholesterol as much as Lipitor, only it was safer, raised HDL,
didn’t lower Co-Q 10, and didn’t adversely affect liver enzymes. Policosanol abstract: "A randomized, double-blind study was
undertaken to compare the efficacy and tolerability of policosanol
(10 mg/day) and lovastatin (20 mg/day) in patients with
hypercholesterolemia and noninsulin dependent diabetes mellitus.
After 6 weeks on a lipid lowering diet, 53 patients were randomized
to receive either policosanol or lovastatin tablets that were taken
for 12 weeks under double-blind conditions. Both groups
significantly (p < 0.001) lowered low-density lipoprotein (LDL)-cholesterol,
total cholesterol and the ratio of LDL-cholesterol to high-density
lipoprotein (HDL)-cholesterol. Comparison between groups showed that
changes in HDL-cholesterol induced by policosanol were significantly
greater (p < 0.01) than those induced by lovastatin. Lovastatin
significantly (p < 0.05) increased levels of aminotransferase,
creatine phosphokinase and alkaline phosphatase. Adverse reactions
were more frequent in the lovastatin group (p < 0.01) than in the
policosanol group. In conclusion, policosanol administered at 10
mg/day produces more advantageous changes in HDL-cholesterol and has
a better safety and tolerability profile than lovastatin 20 mg/day."
(Crespo N et al. Int J Clin Pharmacol Res 1999;19(4):117-27
Comparative study of the efficacy and tolerability of policosanol
and lovastatin in patients with hypercholesterolemia and noninsulin
dependent diabetes mellitus). An added benefit: Policosanol may be good bone support: "In conclusion, policosanol prevented bone loss and decreased bone
resorption in ovariectomized rats, suggesting that it should be
potentially useful in preventing bone loss in postmenopausal women"
(Noa M. Policosanol prevents bone loss in ovariectomized rats. Drugs
Exp Clin Res. 2004;30(3):117-23). Nutri-West’s Total Lipotrophic has 5 mg policosanol PLUS synergistic
factors for maintaining healthy cholesterol levels: garlic, beta
glucan, beta sitosterol, apple pectin, guggulipid, etc. Call
1-800-443-3333 for a Nutri-West distributor near you.
|